A notable structural reallocation of institutional capital has accelerated across global equity markets. Investors are increasingly systematically reducing overextended allocations in heavy-technology equities and redeploying liquidity into U.S. healthcare stocks. This sector rotation comes as the long-running mega-cap technology rally encounters heightened volatility, driven by growing institutional skepticism surrounding multi-billion-dollar artificial intelligence (AI) cap